REINE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
REINE PHARMA
Largest movements
- Receivables within one year +€129,088
up €129,088 (+149%), from €86,820 to €215,908
of which Other amounts receivable: +€118,832
- Intangible fixed assets -€56,412
down €56,412 (-60.0%), from €94,025 to €37,613
- Cash -€35,494
down €35,494 (-53.3%), from €66,587 to €31,093
mainly Receivables within one year (-€129,088) and Current portion of long-term debt (-€29,842)
- Other debts +€67,002
up €67,002 (+11.0%), from €610,849 to €677,851
- Current portion of long-term debt -€29,842
down €29,842 (-66.5%), from €44,897 to €15,054
- Reserves +€29,748
up €29,748 (+38.4%), from €77,486 to €107,234
- Trade debts -€25,015
down €25,015 (-12.0%), from €209,270 to €184,255
- Debts after one year -€15,054
down €15,054 (-100%), from €15,054 to €0
- Gross operating margin -€81,727
down €81,727 (-20.0%), from €408,207 to €326,480
- Staff costs +€13,608
up €13,608 (+8.8%), from €155,274 to €168,881
- Taxes -€10,017
down €10,017 (-49.7%), from €20,165 to €10,148
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,005,535 | €1,028,839 | +€23,304 | +2.3% |
| Fixed assets | 21/28 | €424,373 | €359,801 | -€64,572 | -15.2% |
| Intangible fixed assets | 21 | €94,025 | €37,613 | -€56,412 | -60.0% |
| Tangible fixed assets | 22/27 | €330,348 | €322,188 | -€8,159 | -2.5% |
| Land and buildings | 22 | €322,727 | €311,364 | -€11,364 | -3.5% |
| Plant, machinery and equipment | 23 | €939 | €2,189 | +€1,250 | +133% |
| Furniture and vehicles | 24 | €6,681 | €8,636 | +€1,955 | +29.3% |
| Current assets | 29/58 | €581,162 | €669,038 | +€87,876 | +15.1% |
| Stocks and contracts in progress | 3 | €419,360 | €415,760 | -€3,600 | -0.9% |
| Stocks | 30/36 | €419,360 | €415,760 | -€3,600 | -0.9% |
| Amounts receivable within one year | 40/41 | €86,820 | €215,908 | +€129,088 | +149% |
| Trade receivables | 40 | €81,276 | €91,532 | +€10,256 | +12.6% |
| Other amounts receivable | 41 | €5,544 | €124,376 | +€118,832 | +2,143% |
| Cash at bank and in hand | 54/58 | €66,587 | €31,093 | -€35,494 | -53.3% |
| Deferred charges and accrued income | 490/1 | €8,395 | €6,276 | -€2,119 | -25.2% |
| Total equity and liabilities | 10/49 | €1,005,535 | €1,028,839 | +€23,304 | +2.3% |
| Equity | 10/15 | €96,086 | €125,834 | +€29,748 | +31.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €77,486 | €107,234 | +€29,748 | +38.4% |
| Distributable reserves | 133 | €77,486 | €107,234 | +€29,748 | +38.4% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €909,449 | €903,005 | -€6,444 | -0.7% |
| Amounts payable after more than one year | 17 | €15,054 | €0 | -€15,054 | -100% |
| Financial debts | 170/4 | €15,054 | €0 | -€15,054 | -100% |
| Amounts payable within one year | 42/48 | €884,838 | €898,319 | +€13,482 | +1.5% |
| Current portion of amounts payable after more than one year | 42 | €44,897 | €15,054 | -€29,842 | -66.5% |
| Trade debts | 44 | €209,270 | €184,255 | -€25,015 | -12.0% |
| Suppliers | 440/4 | €209,270 | €184,255 | -€25,015 | -12.0% |
| Taxes, remuneration and social security | 45 | €19,822 | €21,159 | +€1,337 | +6.7% |
| Taxes | 450/3 | €127 | €148 | +€20 | +15.9% |
| Remuneration and social security | 454/9 | €19,695 | €21,012 | +€1,317 | +6.7% |
| Other amounts payable | 47/48 | €610,849 | €677,851 | +€67,002 | +11.0% |
| Accrued charges and deferred income | 492/3 | €9,556 | €4,685 | -€4,871 | -51.0% |
| Remuneration, social security and pensions | 62 | €155,274 | €168,881 | +€13,608 | +8.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €74,262 | €74,677 | +€415 | +0.6% |
| Other operating charges | 640/8 | €5,440 | €5,681 | +€240 | +4.4% |
| Gross operating margin | 9900 | €408,207 | €326,480 | -€81,727 | -20.0% |
| Operating profit (loss) | 9901 | €173,230 | €77,241 | -€95,989 | -55.4% |
| Financial income | 75/76B | €1,220 | €793 | -€427 | -35.0% |
| Recurring financial income | 75 | €1,220 | €793 | -€427 | -35.0% |
| Financial charges | 65/66B | €13,878 | €14,138 | +€260 | +1.9% |
| Recurring financial charges | 65 | €13,878 | €14,138 | +€260 | +1.9% |
| Profit (loss) for the period before taxes | 9903 | €160,572 | €63,896 | -€96,677 | -60.2% |
| Income taxes | 67/77 | €20,165 | €10,148 | -€10,017 | -49.7% |
| Profit (loss) for the period | 9904 | €140,408 | €53,748 | -€86,660 | -61.7% |
| Profit (loss) for the period to be appropriated | 9905 | €140,408 | €53,748 | -€86,660 | -61.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.